Abstract
Sepsis is a perplexing infection-related syndrome documented for thousands of years. It remains a leading cause of mortality and morbidity worldwide. The concepts and understanding of sepsis have evolved in recent decades from a systemic inflammatory response syndrome to infection to, more recently, a life-threatening organ dysfunction due to a dysregulated host response. Clinical recognition of sepsis is often difficult, especially in the early stages of presentation. The disease course of sepsis is also highly variable. Heterogeneity related to age, comorbidity and iatrogenic intervention add further layers of complexity. Specific and sensitive diagnostics to aid identification and guide treatment are still lacking, though novel technologies hold considerable promise. It is now recognized that the biological phenotype of sepsis varies markedly, both between patients and over time. Thus, a one-size-fits-all therapeutic approach is increasingly viewed as over-simplistic, explaining the failure of various strategies in multiple randomized controlled trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Singer M, Deutschmann CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801–10.
Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51.
Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259–72.
World Health Organization. The top 10 causes of death (Fact sheet updated January 2017). http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed 9 Feb 2018.
Kaukonen K-M, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311:1308–16.
Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care--reasons for caution. N Engl J Med. 2014;370:1673–6.
Osler W. Principles and practice of medicine designed for the use of practitioners and students of medicine. 3rd ed. Edinburgh: Pentland; 1898.
Majno G. The ancient riddle of sigma eta psi iota sigma (sepsis). J Infect Dis. 1991;163:937–45.
Haensch S, Bianucci R, Signoli M, et al. Distinct clones of Yersinia pestis caused the black death. PLoS Pathog. 2010;6:e1001134.
Benedictow OJ. The black death 1346–1353: the complete history. Woodbridge: Boydell Press; 2004.
Davaine MC. Recherches sur quelques questions relatives a la septicemie. Paris: G. Masson; 1872.
Lister J. On the antiseptic principle in the practice of surgery. Lancet. 1867;90:353–6.
Fleming A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzæ. Br J Exp Pathol. 1929;10:226–36.
Kelly FE, Fong K, Hirsch N, et al. Intensive care medicine is 60 years old: the history and future of the intensive care unit. Clin Med. 2014;14:376–9.
Thomas L. Germs. N Engl J Med. 1972;287:553–5.
Cerra FB. The systemic septic response: multiple systems organ failure. Crit Care Clin. 1985;1:591–607.
Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res. 1990;49:186–96.
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55.
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–6.
Hotchkiss R, Karl I. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138–50.
Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome. Crit Care Med. 2017;XX:1–10.
van Vught LA, Klein Klouwenberg PMC, Spitoni C, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315:1469.
Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med. 1997;25:1095–100.
Angus DC. The search for effective therapy for sepsis: back to the drawing board? JAMA. 2011;306:2614–5.
Sprung CL, Schein RMH, Balk RA. The new sepsis consensus definitions: the good, the bad and the ugly. Intensive Care Med. 2016;42:2024–6.
Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.
de Grooth H-J, Geenen IL, Girbes AR, et al. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017;21:38.
Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock. Nat Rev Dis Prim. 2016;2:16045.
Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007;35:1599–608.
Haak BW, Wiersinga WJ. The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol. 2017;2:135–43.
Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27:1230–51.
Takasu O, Gaut JP, Watanabe E, et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013;187:509–17.
Singer M, De Santis V, Vitale D, et al. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet (London, England). 2004;364:545–8.
Langley RJ, Tsalik EL, van Velkinburgh JC, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5:195ra95.
Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369:2196–210.
Heffner AC, Horton JM, Marchick MR, et al. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis. 2010;50:814–20.
Pierrakos C, Vincent J-L. Sepsis biomarkers: a review. Crit Care. 2010;14:R15.
Davenport EE, Burnham KL, Radhakrishnan J, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259–71.
Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.
van Vught LA, Holman R, de Jonge E, et al. Diabetes is not associated with increased 90-day mortality risk in critically ill patients with sepsis. Crit Care Med. 2017;45(10):e1026–35. https://doi.org/10.1097/CCM.0000000000002590.
Wan Y-D, Sun T-W, Kan Q-C, et al. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies. Crit Care. 2014;18:R71.
Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock. JAMA. 2013;310:1683.
Wiewel MA, van Vught LA, Scicluna BP, et al. Prior use of calcium channel blockers is associated with decreased mortality in critically ill patients with sepsis: a prospective observational study. Crit Care Med. 2017;45:454–63.
Arabi YM, Dara SI, Tamim HM, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17:R72.
Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72:1491–501.
Angus DC, Carlet J. Surviving intensive care: a report from the 2002 Brussels Roundtable. Intensive Care Med. 2003;29:368–77.
Mehlhorn J, Freytag A, Schmidt K, et al. Rehabilitation interventions for postintensive care syndrome: a systematic review. Crit Care Med. 2014;42:1263–71.
Hutchins NA, Unsinger J, Hotchkiss RS, et al. The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med. 2014;20:224–33.
Daviaud F, Grimaldi D, Dechartres A, et al. Timing and causes of death in septic shock. Ann Intensive Care. 2015;5:16.
Zolfaghari PS, Pinto BB, Dyson A, et al. The metabolic phenotype of rodent sepsis: cause for concern? Intensive Care Med Exp. 2013;1:6.
Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia associated with tooth brushing and dental extraction. Circulation. 2008;117:3118–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Giesen, L., Singer, M. (2018). What Is Sepsis?. In: Wiersinga, W., Seymour, C. (eds) Handbook of Sepsis. Springer, Cham. https://doi.org/10.1007/978-3-319-73506-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-73506-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73505-4
Online ISBN: 978-3-319-73506-1
eBook Packages: MedicineMedicine (R0)